GS
NVO

GTS Securities’s Novo Nordisk NVO Stock Holding History

GTS Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-96,000
Closed -$11.4M – 3153
2024
Q3 		$11.4M Buy
96,000
+8,000
+9% +$1.07M 0.02% 454
2024
Q2 		$12.6M Buy
88,000
+6,800
+8% +$901K 0.03% 407
2024
Q1 		$10.4M Sell
81,200
-36,300
-31% -$4.32M 0.02% 491
2023
Q4 		$12.2M Sell
117,500
-43,700
-27% -$4.32M 0.02% 529
2023
Q3 		$14.7M Buy
+161,200
New +$14.2M 0.03% 442

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GTS Securities's NVO Position: Q2 2026 in Review

GTS Securities opened a new position in Novo Nordisk (NVO) in Q2 2026: 75,048 shares worth $3.6M. The stake represents 0.08% of the portfolio and ranks #153 among its holdings. This is a return to the name: GTS Securities previously reported a position in NVO as recently as Q4 2025.

GTS Securities first reported a position in NVO in Q2 2023 and has held it in 10 quarters since. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • GTS Securities held 75,048 shares of Novo Nordisk worth $3.6M as of Q2 2026.
  • Novo Nordisk was a new GTS Securities position in Q2 2026.
  • Novo Nordisk made up 0.08% of GTS Securities's portfolio in Q2 2026, its #153 holding.
  • GTS Securities first reported a position in Novo Nordisk in Q2 2023 and has held it in 10 quarters since.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.